Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $14.99B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $725.8M | 4.8% |
| Business Acquisitions | $8.55B | 57.1% |
| Stock Repurchases | $5.41B | 36.1% |
| Net Cash Flow | $298.0M | 2.0% |